These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 36407753)
1. Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium. Erglis A; Narbute I; Sondore D; Jegere S; Kumsars I; Dombrovskis A; Grikis K; Briede I; Dombrovska K; Trusinskis K; Grave A; Erglis M; Kalejs M; Stradins P; Strazdins U J Interv Cardiol; 2022; 2022():7934868. PubMed ID: 36407753 [TBL] [Abstract][Full Text] [Related]
2. Optimal Minimal Stent Area and Impact of Stent Underexpansion in Left Main Up-Front 2-Stent Strategy. Kim JH; Kang DY; Ahn JM; Kweon J; Choi Y; Kim H; Lee J; Chae J; Kang SJ; Park DW; Park SJ Circ Cardiovasc Interv; 2024 Jan; 17(1):e013006. PubMed ID: 38227699 [TBL] [Abstract][Full Text] [Related]
3. Single-stent crossover technique from distal unprotected left main coronary artery to the left circumflex artery. Naganuma T; Chieffo A; Basavarajaiah S; Takagi K; Costopoulos C; Latib A; Carlino M; Montorfano M; Bernelli C; Nakamura S; Colombo A Catheter Cardiovasc Interv; 2013 Nov; 82(5):757-64. PubMed ID: 23674385 [TBL] [Abstract][Full Text] [Related]
4. The impact of left circumflex coronary artery ostium stenosis on outcomes for patients after percutaneous coronary intervention for unprotected left main disease. Skorupski WJ; Kałużna-Oleksy M; Mitkowski P; Araszkiewicz A; Skorupski W; Grajek S; Pyda M; Lesiak M; Grygier M Kardiol Pol; 2023; 81(9):903-908. PubMed ID: 37489824 [TBL] [Abstract][Full Text] [Related]
5. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography. Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691 [TBL] [Abstract][Full Text] [Related]
6. Clinical Implications of Bifurcation Angles in Left Main Bifurcation Intervention Using a Two-Stent Technique. Ki YJ; Jung JH; Han JK; Hong S; Cho JH; Gwon HC; Lee SY; Rhew JY; Chae JK; Chae IH; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS J Interv Cardiol; 2020; 2020():2475930. PubMed ID: 32733170 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study. Pavani M; Conrotto F; Cerrato E; D'Ascenzo F; Kawamoto H; Núñez-Gil IJ; Pennone M; Garbo R; Tomassini F; Colombo F; Scacciatella P; Varbella F; Chieffo A; Colombo A; Escaned J J Invasive Cardiol; 2018 Aug; 30(8):276-281. PubMed ID: 30068784 [TBL] [Abstract][Full Text] [Related]
8. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A; JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416 [TBL] [Abstract][Full Text] [Related]
9. The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment. Gil RJ; Bil J; Pawłowski T; Yuldashev N; Kołakowski L; Jańczak J; Jabłoński W; Paliński P Kardiol Pol; 2016; 74(7):627-33. PubMed ID: 26779846 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of simple crossover stenting from the left main to the left anterior descending coronary artery. Lee HM; Nam CW; Cho YK; Yoon HJ; Park HS; Kim H; Chung IS; Heo YS; Hur SH; Kim YN; Kim KB Korean J Intern Med; 2014 Sep; 29(5):597-602. PubMed ID: 25228835 [TBL] [Abstract][Full Text] [Related]
11. Dynamic assessment of the left main-left circumflex bending angle: Implications for ostial left circumflex artery in-stent restenosis after successful two-stent PCI. Wang Z; Yang J; Li C; Huang J; Fezzi S; Chen E; Cai W; Stankovic G; Wijns W; Chen L; Tu S Int J Cardiol; 2023 May; 378():11-19. PubMed ID: 36796487 [TBL] [Abstract][Full Text] [Related]
12. Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial. Chen SL; Zhang JJ; Han Y; Kan J; Chen L; Qiu C; Jiang T; Tao L; Zeng H; Li L; Xia Y; Gao C; Santoso T; Paiboon C; Wang Y; Kwan TW; Ye F; Tian N; Liu Z; Lin S; Lu C; Wen S; Hong L; Zhang Q; Sheiban I; Xu Y; Wang L; Rab TS; Li Z; Cheng G; Cui L; Leon MB; Stone GW J Am Coll Cardiol; 2017 Nov; 70(21):2605-2617. PubMed ID: 29096915 [TBL] [Abstract][Full Text] [Related]
13. Intravascular ultrasound assessment of distal left main bifurcation disease: the importance of the polygon of confluence of the left main, left anterior descending, and left circumflex arteries. Kang SJ; Mintz GS; Oh JH; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ Catheter Cardiovasc Interv; 2013 Nov; 82(5):737-45. PubMed ID: 21805589 [TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic value of Murray law-based quantitative flow ratio in jailed left circumflex coronary artery after left main crossover stenting. Li L; Feng Z; Zhang L; Chen H; Zheng H; Lin H; Jiang Q; Lin Y; Chen L; Fan L Sci Rep; 2023 Mar; 13(1):4391. PubMed ID: 36927741 [TBL] [Abstract][Full Text] [Related]
15. The Cone Flare Crush Modified-T (CFCT) stenting technique for coronary artery bifurcation lesions. Peverill WT; Incani A; Worthley SG; Singbal Y; Garrahy PJ; McCann AB; Cox SV; Moore PT; Lim RYY; Fetahovic T; Connors GW; Hall C; Sieg C; Camuglia AC Int J Cardiol Heart Vasc; 2020 Oct; 30():100643. PubMed ID: 33015315 [TBL] [Abstract][Full Text] [Related]
16. Predictors and 3-year outcomes of compromised left circumflex coronary artery after left main crossover stenting. Ullah H; Elakabawi K; Ke H; Ullah N; Ullah H; Shah SA; Khan HH; Khan MA; Guo N; Yuan Z Clin Cardiol; 2021 Oct; 44(10):1377-1385. PubMed ID: 34269478 [TBL] [Abstract][Full Text] [Related]
17. Double Kissing Mini-Culotte Stenting in Unprotected Distal Left Main Bifurcation Under Optical Coherence Tomography Guidance: Immediate and Short-Term Outcomes. Mukhopadhyay S; Yusuf J; Bansal A; Agrawal R; Mehta V; Gupta MD; M P G; Nigam A; Safal S; Batra V; Kathuria S; Gautam A; Muduli SK; Kurian S Am J Cardiol; 2024 Oct; 229():47-55. PubMed ID: 39173990 [TBL] [Abstract][Full Text] [Related]
18. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds. Puricel S; Arroyo D; Corpataux N; Baeriswyl G; Lehmann S; Kallinikou Z; Muller O; Allard L; Stauffer JC; Togni M; Goy JJ; Cook S J Am Coll Cardiol; 2015 Mar; 65(8):791-801. PubMed ID: 25720622 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of double stent strategy for unprotected left main distal bifurcation lesions using current generation drug eluting stent comparing to early generation drug eluting stent; The Milan and New Tokyo (MITO) registry. Watanabe Y; Mitomo S; Naganuma T; Kawamoto H; Takagi K; Chieffo A; Carlino M; Montorfano M; Nakamura S; Colombo A Catheter Cardiovasc Interv; 2021 Feb; 97(2):E198-E208. PubMed ID: 32384579 [TBL] [Abstract][Full Text] [Related]
20. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions. Naganuma T; Kawamoto H; Panoulas VF; Latib A; Tanaka A; Mitomo S; Ruparelia N; Jabbour RJ; Chieffo A; Carlino M; Montorfano M; Colombo A Int J Cardiol; 2017 Nov; 246():26-31. PubMed ID: 28867010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]